Paul H. O’Brien

933 total citations
36 papers, 742 citations indexed

About

Paul H. O’Brien is a scholar working on Oncology, Pathology and Forensic Medicine and Surgery. According to data from OpenAlex, Paul H. O’Brien has authored 36 papers receiving a total of 742 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 9 papers in Pathology and Forensic Medicine and 8 papers in Surgery. Recurrent topics in Paul H. O’Brien's work include Cutaneous Melanoma Detection and Management (3 papers), Lymphoma Diagnosis and Treatment (3 papers) and Tumors and Oncological Cases (2 papers). Paul H. O’Brien is often cited by papers focused on Cutaneous Melanoma Detection and Management (3 papers), Lymphoma Diagnosis and Treatment (3 papers) and Tumors and Oncological Cases (2 papers). Paul H. O’Brien collaborates with scholars based in United States. Paul H. O’Brien's co-authors include Richard D. Brasfield, Paul L. Baron, John S. Metcalf, David J. Cole, D Catlin, Albert Kreutner, John C. Maize, Joseph Sherman, Deborah Cameron and S. S. Spicer and has published in prestigious journals such as Science, Cancer and Radiology.

In The Last Decade

Paul H. O’Brien

35 papers receiving 656 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul H. O’Brien United States 17 346 198 166 139 111 36 742
Eligio Grigoletto Italy 14 375 1.1× 119 0.6× 178 1.1× 221 1.6× 82 0.7× 54 745
Joanne Stetz United States 7 305 0.9× 287 1.4× 69 0.4× 394 2.8× 168 1.5× 7 867
J.M. Cosset France 15 241 0.7× 121 0.6× 128 0.8× 262 1.9× 76 0.7× 43 814
C. Norman Coleman United States 15 226 0.7× 140 0.7× 332 2.0× 241 1.7× 66 0.6× 25 780
T. Girinsky France 12 250 0.7× 99 0.5× 128 0.8× 90 0.6× 49 0.4× 22 574
T F Pajak United States 17 340 1.0× 279 1.4× 133 0.8× 261 1.9× 260 2.3× 27 878
Anna Russo Italy 18 550 1.6× 247 1.2× 477 2.9× 269 1.9× 89 0.8× 74 1.1k
Roger A. Potish United States 22 243 0.7× 378 1.9× 100 0.6× 203 1.5× 27 0.2× 64 1.3k
Bimal C. Ghosh United States 17 328 0.9× 251 1.3× 272 1.6× 226 1.6× 25 0.2× 74 1.1k
M. V. Williams United Kingdom 11 186 0.5× 184 0.9× 96 0.6× 231 1.7× 26 0.2× 25 644

Countries citing papers authored by Paul H. O’Brien

Since Specialization
Citations

This map shows the geographic impact of Paul H. O’Brien's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul H. O’Brien with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul H. O’Brien more than expected).

Fields of papers citing papers by Paul H. O’Brien

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul H. O’Brien. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul H. O’Brien. The network helps show where Paul H. O’Brien may publish in the future.

Co-authorship network of co-authors of Paul H. O’Brien

This figure shows the co-authorship network connecting the top 25 collaborators of Paul H. O’Brien. A scholar is included among the top collaborators of Paul H. O’Brien based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul H. O’Brien. Paul H. O’Brien is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Klein, Benjamin, Paul H. O’Brien, Lin Zhang, et al.. (2025). Epidermal Interferon‐κ Drives Cutaneous Lupus‐Like Lesions, Photosensitivity, and Systemic Autoimmunity In Vivo. Arthritis & Rheumatology. 78(1). 184–197. 1 indexed citations
2.
O’Brien, Paul H., et al.. (2013). Neuroblastoma in an adult: case presentation and literature review.. PubMed. 43(1). 81–4. 10 indexed citations
3.
O’Brien, Paul H., et al.. (2012). Cytotoxic effects of silver nanoparticles on DNA repair proficient and deficient mouse embryonic fibroblasts. Mutagenesis. 27(6). 810–810. 1 indexed citations
4.
Nguyen, Christophe, David J. Cole, Paul H. O’Brien, et al.. (2001). Melanoma thickness and histology predict sentinel lymph node status. The American Journal of Surgery. 181(1). 8–11. 58 indexed citations
5.
McClay, Edward F., Paul L. Baron, David J. Cole, et al.. (2000). The effect of tamoxifen and cisplatin on the disease-free and overall survival of patients with high risk malignant melanoma. British Journal of Cancer. 83(1). 16–21. 21 indexed citations
6.
Cole, David J., Steven D. Schwaitzberg, David B. Adams, et al.. (1999). A pilot study evaluating the efficacy of a fully acetylated poly-N-acetyl glucosamine membrane formulation as a topical hemostatic agent. Surgery. 126(3). 510–517. 48 indexed citations
7.
Baron, Paul L., Paul H. O’Brien, Bruce M. Elliott, et al.. (1998). Detection of Occult Breast Cancer Micrometastases in Axillary Lymph Nodes Using a Multimarker Reverse Transcriptase-Polymerase Chain Reaction Panel. Journal of the American College of Surgeons. 187(1). 9–16. 40 indexed citations
8.
Baron, Paul L., et al.. (1997). Stereotactic core biopsy of the breast: results of one-year follow-up of 101 patients.. PubMed. 63(12). 1124–7. 11 indexed citations
9.
O’Brien, Paul H.. (1993). Surgical Management of Unusual Clinical Presentations of Malignant Lymphoma. Surgical Oncology Clinics of North America. 2(2). 243–250. 1 indexed citations
10.
Keil, Jan, et al.. (1991). Breast Cancer Screening in a Biracial Community: The Charleston Tricounty Experience. Southern Medical Journal. 84(7). 862–866. 13 indexed citations
11.
Snyder, Harry W., David H. Henry, Gerald L. Messerschmidt, et al.. (1991). Minimal toxicity during protein a immunoadsorption treatment of malignant disease: An outpatient therapy. Journal of Clinical Apheresis. 6(1). 1–10. 20 indexed citations
12.
Ainsworth, Sterling K., et al.. (1988). Toxicity following protein a treatment of metastatic breast adenocarcinoma. Cancer. 61(8). 1495–1500. 18 indexed citations
13.
Kreutner, Albert, et al.. (1980). Granular cell myoblastoma.. PubMed. 150(5). 703–10. 40 indexed citations
14.
Goust, J M, Betty S. Roof, H. Hugh Fudenberg, & Paul H. O’Brien. (1979). T-cell markers in breast cancer patients at diagnosis. Clinical Immunology and Immunopathology. 12(4). 396–403. 9 indexed citations
15.
O’Brien, Paul H., et al.. (1971). Distant metastases in epidermoid cell carcinoma of the head and neck. Cancer. 27(2). 304–307. 98 indexed citations
16.
Bertino, Joseph R., Paul H. O’Brien, & Jerry L. McCullough. (1971). Inhibition of Growth of Leukemia Cells by Enzymic Folate Depletion. Science. 172(3979). 161–162. 20 indexed citations
17.
O’Brien, Paul H., et al.. (1970). Effect of Irradiation on Tumor-Infused Lymph Nodes. Radiology. 94(2). 407–411. 8 indexed citations
18.
Midell, Allen I., et al.. (1970). Primary leiomyosarcomas of the inferior vena cava. Report of a case and review of the literature. Cancer. 26(6). 1349–1353. 31 indexed citations
19.
O’Brien, Paul H., et al.. (1968). The Effect of Acute Anemia on the Radiosensitivity of V2Rabbit Sarcoma. Radiology. 91(6). 1159–1162. 7 indexed citations
20.
O’Brien, Paul H.. (1968). Medical record linkage. Journal of Chronic Diseases. 21(1). 56–56. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026